META vs RDIB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across profitability, leverage, and operating efficiency. While the current price of $612.42 trades at a premium to the Graham Number ($213.17) and the growth-based Intrinsic Value ($542.14), the PEG ratio of 0.94 suggests the stock is undervalued relative to its high growth rate. Strong revenue growth (23.8%) and a low forward P/E (17.03) outweigh the bearish technical trend and insider selling. The company's dominant market position and consistent earnings beats support a bullish long-term outlook.
RDIB exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9 and a negative Price/Book ratio of -12.44, indicating negative shareholder equity. The company is facing a liquidity crisis with a Current Ratio of 0.17 and a Quick Ratio of 0.12, suggesting it cannot meet its short-term obligations. Revenue is in a clear decline, dropping 14.20% year-over-year, while profit margins remain negative. Combined with a 0/100 technical trend and poor insider sentiment, the data suggests a high risk of insolvency or significant capital impairment.
Compare Another Pair
Related Comparisons
META vs RDIB: Head-to-Head Comparison
This page compares Meta Platforms, Inc. (META) and Reading International, Inc. (RDIB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.